CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

Posts Tagged ‘Scientific Sessions’

January 31st, 2014

American College of Cardiology Announces Late-Breaking Clinical Trials

The American College of Cardiology announced the lineup of late-breaking clinical trials for its upcoming annual meeting in Washington, DC. The opening session will include the most eagerly anticipated trials — the main results of Symplicity HTN-3 and the  comparison of Corevalve and surgery in high-risk patients. Subsequent sessions will include several phase-3 trials of  PCSK9 inhibitors. Here […]

Categories: General
Tags: , ,

January 22nd, 2013

Trials of Niacin and AF Device Will Headline American College of Cardiology Program

Two big trials will highlight this year’s American College of Cardiology (ACC) meeting in March in San Francisco. First is the PREVAIL trial testing Boston Scientific’s long-anticipated Watchman left atrial appendage closure device for stroke prevention in patients with atrial fibrillation (AF). Second is the detailed presentation of the controversial failed HPS2-THRIVE trial of extended-release niacin and laropiprant. The […]

Categories: Cardiac Surgery, Electrophysiology, General, Heart Failure, Prevention
Tags: , , , , ,

November 1st, 2010

AHA Preview: What Is Clyde Yancy Looking Forward to Seeing?

In the first installment of our AHA Preview series, we ask Clyde Yancy, medical director of the Baylor Heart and Vascular Institute and chief of Cardiothoracic Transplantation at Baylor University Medical Center, to list the trials in his field that he is most looking forward to at the AHA Scientific Sessions 2010 meeting.  See what […]

Categories: General, Heart Failure
Tags: , ,